Abecassis

Harris Williams Hires Jonathan Abecassis as Managing Director, Private Capital Advisory

Retrieved on: 
Tuesday, January 9, 2024

Harris Williams, a global investment bank specializing in M&A and private capital advisory services, today announced that Jonathan Abecassis has joined the firm’s London office as a managing director in the firm’s Private Capital Advisory Group, focused on providing a full range of primary and secondary advisory and related capabilities for clients in Europe.

Key Points: 
  • Harris Williams, a global investment bank specializing in M&A and private capital advisory services, today announced that Jonathan Abecassis has joined the firm’s London office as a managing director in the firm’s Private Capital Advisory Group, focused on providing a full range of primary and secondary advisory and related capabilities for clients in Europe.
  • Mr. Abecassis most recently served as a managing director and head of capital solutions and GP advisory in the EMEA and APAC regions at Credit Suisse.
  • “Jonathan is an exceptionally experienced advisor with a deep network of institutional relationships, and we believe his addition to our Private Capital Advisory Group will accelerate our ongoing growth and success throughout Europe.”
    Eric Zoller, managing director and head of private capital advisory at Harris Williams, said, “Jonathan brings nearly two decades of experience advising a range of clients across the spectrum of GP-led structures, LP fund interests, and direct minority and control investments.
  • I am excited to join the firm at this inflection point for the Private Capital Advisory Group.”
    Mr. Abecassis earned a B.A.

Braven Launches New Unit to Invest In the Next Generation of Healthcare & Life Science Innovators

Retrieved on: 
Friday, July 7, 2023

Co-led by William Abecassis, Braven’s Managing Partner, and Dr. Sean Khozin, Senior Life Sciences & Healthcare Partner, the Unit supports the firm’s unique ‘co-building’ investment strategy.

Key Points: 
  • Co-led by William Abecassis, Braven’s Managing Partner, and Dr. Sean Khozin, Senior Life Sciences & Healthcare Partner, the Unit supports the firm’s unique ‘co-building’ investment strategy.
  • "Across healthcare and life sciences, there are countless opportunities for innovation.
  • To augment the Unit's capabilities, Braven has enlisted a team of specialized fellows with expertise spanning from pharma development to healthcare provision.
  • Braven is an early-stage investment firm focused on breakthrough innovation within regulated ecosystems, starting with financial services, insurance, and healthcare.

BRAVEN LAUNCHES NEW MODEL OF VENTURE CAPITAL TO INVEST WHERE DEEP TECHNOLOGIES ARE REMAKING REGULATED INDUSTRIES

Retrieved on: 
Friday, December 2, 2022

NEW YORK, Dec. 2, 2022 /PRNewswire/ -- Braven, a venture capital firm pioneering a new operating model to co-build breakthrough early-stage startups, announces its launch as a joint venture with 26North Partners LP (26North), a next-generation alternative asset firm founded by private equity leader and philanthropist Josh Harris.

Key Points: 
  • Braven, a VC firm with a new operating model to co-build early-stage startups, launches as a joint venture with 26North.
  • The firm invests where deep scientific and technical innovation is transforming the large, regulated industries that underpin society, such as finance, healthcare, defense, and industrial infrastructure.
  • Braven is led by William Abecassis, founder and former head of BlackRock's Innovation Capital venture group.
  • Braven has engineered a new model of venture capital, designed to help visionary companies break through the barriers of these complex legacy industries and reshape them for the better.